| Mahavir Advanced Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531689 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE716N01016 |
Div & Yield% : - |
EPS(TTM) : 0.19 |
|
Book Value(₹) : 7.84 |
Market Cap(₹Cr) : 171.14 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Dec 2013 | Sep 2013 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.03 | 0.13 | 0.02 | 0.02 | 0.03 | 0.03 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.03 | 0.13 | 0.02 | 0.02 | 0.03 | 0.03 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.26 | 0.00 | 0.00 |
| Total Income | 0.03 | 0.13 | 0.02 | 0.28 | 0.03 | 0.03 |
| Total Expenditure | 0.02 | 0.02 | 0.02 | 0.15 | 0.01 | 0.05 |
| PBIDT | 0.01 | 0.11 | 0.01 | 0.13 | 0.02 | -0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 0.01 | 0.11 | 0.01 | 0.13 | 0.02 | -0.02 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.01 | 0.11 | 0.01 | 0.13 | 0.02 | -0.02 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | -0.04 |
| Adjusted Profit After Extra-ordinary item | 0.01 | 0.11 | 0.01 | 0.09 | 0.02 | 0.02 |
| EPS (Unit Curr.) | 0.01 | 0.10 | 0.01 | 0.11 | 0.02 | -0.02 |
| EPS (Adj) (Unit Curr.) | 0.01 | 0.10 | 0.01 | 0.11 | 0.02 | -0.02 |
| Calculated EPS (Unit Curr.) | 0.01 | 0.10 | 0.01 | 0.11 | 0.02 | 0.00 |
| Calculated EPS (Adj) (Unit Curr.) | 0.01 | 0.10 | 0.01 | 0.11 | 0.02 | 0.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.05 | 0.38 | 0.03 | 0.46 | 0.06 | 0.00 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.05 | 0.38 | 0.03 | 0.46 | 0.06 | 0.00 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.36 | 11.36 | 11.36 | 11.36 | 11.36 | 11.36 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 11,249,550.00 | 11,249,550.00 | 11,249,550.00 | 11,249,550.00 | 10,438,800.00 | 10,438,800.00 |
| Public Shareholding (% in Equity) | 99.03 | 99.03 | 99.03 | 99.03 | 91.90 | 91.90 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 109,650.00 | 109,650.00 | 109,650.00 | 109,650.00 | 920,400.00 | 920,400.00 |
| Non Encumbered - % in Total Promoters Holding | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Non Encumbered - % in Total Equity | 0.97 | 0.97 | 0.97 | 0.97 | 8.10 | 8.10 |
| PBIDTM(%) | 33.33 | 84.62 | 50.00 | 650.00 | 66.67 | -66.67 |
| PBDTM(%) | 33.33 | 84.62 | 50.00 | 650.00 | 66.67 | -66.67 |
| PATM(%) | 33.33 | 84.62 | 50.00 | 650.00 | 66.67 | -66.67 |